MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 Views
administrator
administrator
07/04/23

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next